Physician profile
Brad E Hanstad
NPI 1609856236
$3,959.94
in general payments reported to CMS, 2019-2025
16 companies · $991 in 2025
The $991 reported for 2025 was more than what 91% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $318 · 2020: $95.93 · 2021: $709 · 2022: $1,107 · 2023: $426 · 2024: $313 · 2025: $991.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,730.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,730.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,062.50 | 2019-2025 | Total30, Precision7, Dailies Total1 |
| Johnson & Johnson Vision Care, INC. | $816.84 | 2019-2025 | Acuvue |
| Biotissue Holdings INC. | $764.55 | 2022-2025 | |
| Coopervision INC. | $529.63 | 2019-2025 | Myday Contact Lens, Misight Contact Lens, Paragon Crt |
| Bausch & Lomb Americas INC. | $218.32 | 2023-2025 | Infuse, Xiidra |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $147.94 | 2019-2021 | |
| Ocular Therapeutix, INC. | $97.62 | 2021 | |
| Sun Pharmaceutical Industries INC. | $73.77 | 2022-2025 | Cequa |
| Tarsus Pharmaceuticals, INC. | $64.97 | 2025 | Xdemvy |
| Astellas Pharma US INC | $48.54 | 2025 | Izervay |
| Baxter Healthcare | $35.59 | 2022 | |
| Dompe US, INC. | $31.27 | 2025 | Oxervate |
| Allergan, INC. | $20.60 | 2022 | |
| Thea Pharma INC. | $17.88 | 2025 | Iyuzeh |
| Glaukos Corporation | $17.32 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Visioneering Technologies, INC. | $12.60 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brad Hanstad listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.